These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27373496)

  • 61. Effects of glutamine for prevention of radiation-induced esophagitis: a double-blind placebo-controlled trial.
    Alshawa A; Cadena AP; Stephen B; Reddy A; Mendoza TR; McQuinn L; Lawhorn K; Zarifa A; Bernhardt AM; Fessaheye S; Warneke CL; Chang JY; Naing A
    Invest New Drugs; 2021 Aug; 39(4):1113-1122. PubMed ID: 33580845
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Phase I study of concurrent chemoradiation with pemetrexed and cisplatin followed by consolidation pemetrexed for patients with unresectable stage III non-small cell lung cancer.
    Cardenal F; Arnaiz MD; Morán T; Jové J; Nadal E; Porta R; Solé JM; Brao I; Palmero R; Fuentes R; Núñez I; Caveda E; Cassinello A
    Lung Cancer; 2011 Oct; 74(1):69-74. PubMed ID: 21353323
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Non-small-cell Lung Cancer Developing After Surgery.
    Nakamichi S; Horinouchi H; Asao T; Goto Y; Kanda S; Fujiwara Y; Nokihara H; Yamamoto N; Ito Y; Watanabe SI; Ohe Y
    Clin Lung Cancer; 2017 Nov; 18(6):e441-e448. PubMed ID: 28583380
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy.
    Manapov F; Sepe S; Niyazi M; Belka C; Friedel G; Budach W
    Radiat Oncol; 2013 May; 8():122. PubMed ID: 23680396
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
    Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
    Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical and dosimetric risk factors of acute esophagitis in patients treated with 3-dimensional conformal radiotherapy for non-small-cell lung cancer.
    Zhang ZC; Xu J; Li BS; Zhou T; Lu J; Wang ZT; Li HS; Sun HF; Zhu J; Yu JM
    Am J Clin Oncol; 2010 Jun; 33(3):271-5. PubMed ID: 19823071
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer.
    Lin J; Peng J; Qdaisat A; Li L; Chen G; Lu Z; Wu X; Gao Y; Zeng Z; Ding P; Pan Z
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2551-2560. PubMed ID: 27613188
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Accelerated hypofractionated radiation therapy (AHRT) for non-small-cell lung cancer: can we leave standard fractionation?
    de Dios NR; Sanz X; Foro P; Membrive I; Reig A; Ortiz A; Jiménez R; Algara M
    Clin Transl Oncol; 2017 Apr; 19(4):440-447. PubMed ID: 27553602
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer.
    Dandekar VK; Young J; Kiel K; Bonomi P; Fidler MJ; Batus M; Sher DJ
    Am J Clin Oncol; 2015 Dec; 38(6):605-9. PubMed ID: 24781341
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Randomized double-blind trial of combined modality treatment with or without amifostine in unresectable stage III non-small-cell lung cancer.
    Leong SS; Tan EH; Fong KW; Wilder-Smith E; Ong YK; Tai BC; Chew L; Lim SH; Wee J; Lee KM; Foo KF; Ang P; Ang PT
    J Clin Oncol; 2003 May; 21(9):1767-74. PubMed ID: 12721253
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer.
    Sher DJ; Fidler MJ; Liptay MJ; Koshy M
    Lung Cancer; 2015 Jun; 88(3):267-74. PubMed ID: 25862147
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0501.
    Nogami N; Takigawa N; Hotta K; Segawa Y; Kato Y; Kozuki T; Oze I; Kishino D; Aoe K; Ueoka H; Kuyama S; Harita S; Okada T; Hosokawa S; Inoue K; Gemba K; Shibayama T; Tabata M; Takemoto M; Kanazawa S; Tanimoto M; Kiura K
    Lung Cancer; 2015 Feb; 87(2):141-7. PubMed ID: 25534129
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401.
    Ninomiya K; Yokoyama T; Hotta K; Oze I; Katsui K; Hata T; Yoshioka H; Bessho A; Hosokawa S; Kuyama S; Kudo K; Kozuki T; Harada D; Yasugi M; Murakami T; Nakanishi M; Takigawa N; Maeda Y; Kiura K;
    Support Care Cancer; 2021 Sep; 29(9):5237-5244. PubMed ID: 33649919
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity.
    Socinski MA; Zhang C; Herndon JE; Dillman RO; Clamon G; Vokes E; Akerley W; Crawford J; Perry MC; Seagren SL; Green MR
    Ann Oncol; 2004 Jul; 15(7):1033-41. PubMed ID: 15205196
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A prospective, three-arm, randomized trial of EGCG for preventing radiation-induced esophagitis in lung cancer patients receiving radiotherapy.
    Zhao H; Jia L; Chen G; Li X; Meng X; Zhao X; Xing L; Zhu W
    Radiother Oncol; 2019 Aug; 137():186-191. PubMed ID: 30898322
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Simultaneously modulated accelerated radiation therapy reduces severe oesophageal toxicity in concomitant chemoradiotherapy of locally advanced non-small-cell lung cancer.
    Chajon E; Bellec J; Castelli J; Corre R; Kerjouan M; Le Prisé E; De Crevoisier R
    Br J Radiol; 2015; 88(1056):20150311. PubMed ID: 26414340
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Salvage Concurrent Chemo-radiation Therapy for Loco-regional Recurrence Following Curative Surgery of Non-small Cell Lung Cancer.
    Lee KH; Ahn YC; Pyo H; Noh JM; Park SG; Kim TG; Lee E; Nam H; Lee H; Sun JM; Ahn JS; Ahn MJ; Park K
    Cancer Res Treat; 2019 Apr; 51(2):769-776. PubMed ID: 30205417
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Real-World Treatment of Stage III NSCLC: The Role of Trimodality Treatment in the Era of Immunotherapy.
    Moore S; Leung B; Wu J; Ho C
    J Thorac Oncol; 2019 Aug; 14(8):1430-1439. PubMed ID: 31002953
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Induction Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer].
    Miura A; Soh J; Shien K; Yamamoto H; Toyooka S
    Kyobu Geka; 2018 Apr; 71(4):270-277. PubMed ID: 29755100
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Clinical outcomes and prognostic factors in limited-stage small cell lung cancer: a single institution experience].
    Zhang W; Zhu H; Zhou Z; Feng Q; Chen D; Zhang H; Xiao Z; Wang L
    Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):223-6. PubMed ID: 25975794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.